Trastuzumab Recruiting Phase 2 Trials for Neoplasms / Tumors, Solid / Bladder Cancers / Salivary Cancer / Biliary Cancer Treatment
Indications | Status | Purpose | Phase |
---|---|---|---|
Recruiting | Treatment | 2 |
clinicaltrials.gov Identifier | Title | Drugs |
---|---|---|
NCT02091141 | My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors |